CYNATA THERAPEUTICS LTD has a total of 52 patent applications. It increased the IP activity by 50.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are BUNDESREPUBLIK DEUTSCHLAND LET, MACFARLANE BURNET CT FOR MEDIC and ONYX PHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Australia | 5 | |
#3 | Brazil | 5 | |
#4 | Canada | 5 | |
#5 | EPO (European Patent Office) | 5 | |
#6 | Singapore | 5 | |
#7 | China | 4 | |
#8 | Republic of Korea | 4 | |
#9 | Mexico | 4 | |
#10 | United States | 4 | |
#11 | Taiwan | 3 | |
#12 | Argentina | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Measuring microorganism processes | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Slukvin Igor | 31 |
#2 | Drier Diana | 16 |
#3 | Hei Derek | 16 |
#4 | Kelly Kilian | 15 |
#5 | Samuel Chrishan | 10 |
#6 | Royce Simon | 10 |
#7 | Igor Slukvin | 8 |
#8 | Uenishi Gene | 8 |
#9 | Derek Hei | 4 |
#10 | Diana Drier | 4 |
Publication | Filing date | Title |
---|---|---|
TW202045716A | Method for improving angiogenic potential of a mesenchymal stem cell | |
EP3681519A1 | Method for treating allergic airways disease (aad)/ asthma | |
CA3066799A1 | Method for treating a side effect of immunotherapy | |
AU2018248071A1 | Method for treating a side effect of chimeric antigen receptor (CAR) T cell therapy | |
EP3541924A1 | Pluripotent stem cell assay | |
WO2017156580A1 | Colony forming medium and use thereof |